EC Nutrition

The prostate gland is a major source of serious health problems for men. It is susceptible to the most common chronic inflammatory condition, benign prostatic hyperplasia (BPH), and prostate cancer is the most common malignancy. Age is a key risk factor for both BPH and prostate cancer, but diet, physical activity, and exposure to toxins also contribute to risk. BPH is specifically associated with hormonal changes that occur as men age. Family history is a predictor of prostate cancer.

Chronic inflammation is itself a risk factor for cancer and there is evidence that BPH is a forerunner of prostate cancer. At the molecular level, alterations in DNA structure characteristic of all cancers, are detected in the DNA from BPH tissues independently of the more extensive damage seen in the DNA from prostate tumors [1]. At the level of therapy, two plant extracts (Pao pereira and Rauwolfia vomitoria) that react with this damaged DNA and induce apoptosis in cancer cells have demonstrated effectiveness against prostate cancer and advanced prostate cancer [2-5]. Recent research from Dr. Jun Yan’s laboratory at Nanjing University, sponsored by the Beljanski Foundation, shows that both extracts are also remarkably effective for BPH in an animal model: the androgen imbalance seen in older men is corrected, the prostate is reduced to normal size and the inflammatory condition is directly suppressed [6-9]. The effects of the extracts demonstrate that BPH is reversible.

 Keywords: Benign Prostatic Hyperplasia (BPH); Prostate Gland; Prostate Cancer; Pao pereira; Rauwolfia vomitoria

1. Malins D., et al. “Models of DNA structure achieve almost perfect discrimination between normal prostate, benign prostatic hyperplasia (BPH), and adenocarcinoma and have a high potential for predicting BPH and prostate cancer”. Proceedings of the National Academy of Sciences of the United States of America 1 (1997): 259-264.
2. Beljanski M and Beljanski MS. “Three alkaloids as selective destroyers of cancer cells in mice. Synergy with classic anticancer drugs”. Oncology3 (1986): 198-203.
3. Bemis D., et al. “Anti-prostate cancer activity of a ß-carboline alkaloid enriched extract from Rauwolfia vomitoria”. International Journal of Oncology5 (2006): 1065-1073.
4. Bemis D., et al. “Beta-carboline alkaloid-enriched extract from the amazonian rain forest tree pao pereira suppresses prostate cancer cells”. Journal of the Society for Integrative Oncology2 (2009): 59-65.
5. Chang C., et al. “Pao pereira extract suppresses castration resistant prostate cancer cell growth, survival and invasion through inhibition of NFκB signaling”. Integrative Cancer Therapies 3 (2014): 249-258.
6. Liu J., et al. “Pao pereira extract attenuates testosterone-induced benign prostatic hyperplasia in rats by inhibiting 5α-reductase”. Scientific Reports 9 (2019): 19703.
7. Dong Y., et al. “Pao pereira extract suppresses benign prostatic hyperplasia by inhibiting inflammation-associated NFκB signaling”. BMC Complementary Medicine and Therapies1 (2020): 150.
8. Fang T., et al. “Rauwolfia vomitoria extract suppresses benign prostatic hyperplasia by reducing androgen receptor and 5α-reductase expression in a rat model”. Journal of Integrative Medicine 3 (2020): 258-264.
9. Huang G., et al. “Rauwolfia vomitoria extract suppresses benign prostatic hyperplasia by inducing autophagic apoptosis through endoplasmic reticulum stress”. BMC Complementary Medicine and Therapies 1 (2022): 125.
10. Begley LA., et al. “CXCL5 promotes prostate cancer progression”. Neoplasia3 (2008): 244-254.
11. Beljanski M. “The anticancer agent PB-100, selectively active on malignant cells, inhibits multiplication of sixteen malignant cell lines, even multidrug resistant”. Genetics and Molecular Biology1 (2000): 29.